Barclays’s PRA Health Sciences, Inc. PRAH Stock Holding History

Barclays’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,005,836	Closed	-$166M	–	4255
2021 Q2	$166M	Buy	1,005,836 +360,272	+56%	+$59.5M	0.08%	154
2021 Q1	$99M	Buy	645,564 +586,915	+1,001%	+$90M	0.05%	195
2020 Q4	$7.36M	Buy	58,649 +42,385	+261%	+$5.32M	﹤0.01%	867
2020 Q3	$1.65M	Sell	16,264 -3,491	-18%	-$354K	﹤0.01%	1619
2020 Q2	$1.92M	Sell	19,755 -1,125	-5%	-$109K	﹤0.01%	1501
2020 Q1	$1.73M	Sell	20,880 -79,120	-79%	-$6.57M	﹤0.01%	1412
2019 Q4	$11.1M	Buy	100,000 +42,715	+75%	+$4.75M	0.01%	799
2019 Q3	$5.69M	Sell	57,285 -5,014	-8%	-$498K	﹤0.01%	1026
2019 Q2	$6.18M	Buy	62,299 +23,558	+61%	+$2.34M	﹤0.01%	996
2019 Q1	$4.27M	Buy	38,741 +620	+2%	+$68.4K	﹤0.01%	1054
2018 Q4	$3.51M	Buy	38,121 +13,162	+53%	+$1.21M	﹤0.01%	1078
2018 Q3	$2.75M	Sell	24,959 -45,858	-65%	-$5.05M	﹤0.01%	1522
2018 Q2	$6.61M	Buy	70,817 +53,364	+306%	+$4.98M	0.01%	887
2018 Q1	$1.45M	Buy	17,453 +9,489	+119%	+$787K	﹤0.01%	1558
2017 Q4	$725K	Sell	7,964 -26,243	-77%	-$2.39M	﹤0.01%	1835
2017 Q3	$2.61M	Buy	34,207 +4,944	+17%	+$377K	﹤0.01%	1093
2017 Q2	$2.2M	Sell	29,263 -2,156	-7%	-$162K	﹤0.01%	1161
2017 Q1	$2.05M	Sell	31,419 -28,858	-48%	-$1.88M	﹤0.01%	1199
2016 Q4	$3.32M	Buy	60,277 +34,522	+134%	+$1.9M	﹤0.01%	916
2016 Q3	$1.46M	Sell	25,755 -2,956	-10%	-$167K	﹤0.01%	1217
2016 Q2	$1.2M	Sell	28,711 -1,901	-6%	-$79.4K	﹤0.01%	1362
2016 Q1	$1.29M	Buy	30,612 +24,114	+371%	+$1.01M	﹤0.01%	1292
2015 Q4	$293K	Sell	6,498 -896	-12%	-$40.4K	﹤0.01%	1888
2015 Q3	$281K	Sell	7,394 -2,661	-26%	-$101K	﹤0.01%	1979
2015 Q2	$362K	Buy	10,055 +9,470	+1,619%	+$341K	﹤0.01%	1874
2015 Q1	$16K	Sell	585 -528	-47%	-$14.4K	﹤0.01%	3204
2014 Q4	$27K	Buy	+1,113	New	+$27K	﹤0.01%	3306